Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Interview: Exploring NHS market reforms and the UK healthcare investment landscape with Sharon Lamb, Partner at McDermott Will & Emery

With record NHS waiting lists and major structural reforms underway, private healthcare investment in the UK continues to show resilience amidst broader economic uncertainties. Recent government action to transform the NHS are creating new market dynamics, yet investor appetite remains strong, particularly in subsectors serving patients seeking alternatives to lengthy NHS queues. HBI spoke with […]

NHS app becomes default route for GP registration

UK NHS patients can now instantly register with a GP on the NHS APP, and will soon be able to view and manage hospital appointments, and select from a greater number of providers, including independent sector providers, and receive test results straight through the app.

KKR offers $1.2 billion for Sweden’s Biotage

RWK BidCo, a newly formed company wholly owned by global investment firm KKR Funds with the purpose of making the offer in deals, has announced a recommended public offer to the shareholders of Biotage, valuing it at around 1.6 billion SEK ($1.22 billion).

DCC to sell healthcare division for £1.05 billion

DCC, A Dublin-based and London Stock Exchange-listed sales, marketing and support services group, has announced it has entered into a definitive agreement to sell its healthcare division to HealthCo, an investment vehicle of funds managed by European private equity firm Investindustrial Advisors, for £1.05 billion (approximately €1.23 billion).

‘Saudization’ kickstarts in Saudi Arabia’s healthcare sector

The first phase of ‘Saudization’ in Saudi Arabia’s healthcare sector is now underway, effective from 17 April. Saudization is a government policy to increase the number of Saudi nationals employed and reduce the reliance on expats in the workforce. 

Chaos and opportunity — The impact of Trump’s trade war on Europe’s healthcare sector

Europe’s healthcare providers are less directly exposed to Donald Trump’s trade war than its med tech sector. But hospital and outpatient groups will still suffer. The severity of the pain will depend largely on the EU’s response to US tariffs, in particular the level and extent of possible counter tariffs. The EU could also be galvanised into better supporting innovation and R&D in its med tech and pharma sectors.

FREE BLOG AI is no longer a future promise — it is already transforming drug discovery

Last week, HBI sat down with Chris Meier, Managing Director and Partner at Boston Consulting Group (BCG), an American global management consulting firm, to explore how AI is transforming drug discovery. Bringing a new drug to market typically takes 12 to 15 years and costs upwards of $2.5 billion, with only a small percentage making […]

Generali Investments and Partners Group launch new private credit secondaries fund

Generali Investments, a platform of asset management firms with €645.2 billion in assets under management (as of December 31, 2024) together with Partners Group, a Swiss-based global private equity firm, are launching a new private credit secondaries fund. The launch of Generali Investments' ‘Private Credit Secondaries Fund’ signals not only the growing maturity of the private credit market but also its strategic importance for sectors like healthcare.

Find Us